Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension
NCT02216279
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Hypertension
Interventions
DRUG:
PulmoBind
Sponsor
Montreal Heart Institute